ROME and MILAN, Oct. 3, 2025 /PRNewswire/ -- The Department of Clinical and Molecular Medicine of Sapienza University of Rome (DMCM), Takis S.r.l. and Tethis S.p.A. today announce a joint initiative, to accelerate research on HER3-targeted therapies and advance the development of...
Hence then, the article about the department of clinical and molecular medicine of sapienza university of rome takis and tethis start a collaboration to advance her3 targeted therapies and diagnostics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Department of Clinical and Molecular Medicine of Sapienza University of Rome, Takis and Tethis start a collaboration to advance HER3-targeted therapies and diagnostics )
Also on site :
- US cable outlines new ‘construct’ to control Strait of Hormuz – media
- ’80s Thrash Metal Frontman, Who Survived Rare Cancer, Announces New Project
- Why are Western feminists silent on the war on Iranian women?